INSERM, ERI 12 and University Hospital Amiens, France.
Circ Cardiovasc Imaging. 2011 Sep;4(5):473-81. doi: 10.1161/CIRCIMAGING.110.961011. Epub 2011 Jul 7.
Left atrium (LA) enlargement is common in organic mitral regurgitation (MR) and is an emerging prognostic indicator. However, outcome implications of LA enlargement have not been analyzed in the context of routine clinical practice and in a multicenter study.
The Mitral Regurgitation International DAtabase (MIDA) registry enrolls patients with organic MR due to flail leaflets, diagnosed in routine clinical practice, in 5 US and European centers. We investigated the relation between LA diameter and mortality under medical treatment and after mitral surgery in 788 patients in sinus rhythm (64±12 years; median LA, 48 [43 to 52] mm). LA diameter was independently associated with survival after diagnosis (hazard ratio, 1.08 [1.04 to 1.12] per 1 mm increment). Compared with patients with LA <55 mm, those with LA ≥55 mm had lower 8-year overall survival (P<0.001). LA ≥55 mm independently predicted overall mortality (hazard ratio, 3.67 [1.95 to 6.88]) and cardiac mortality (hazard ratio, 3.74 [1.72 to 8.13]) under medical treatment. The association of LA ≥55 mm and mortality was consistent in subgroups. Similar excess mortality associated with LA ≥55 mm was observed in asymptomatic and symptomatic patients (P for interaction, 0.77). In patients who underwent mitral surgery, LA ≥55 mm had no impact on postoperative outcome (P>0.20). Mitral surgery was associated with greater survival benefit in patients with LA ≥55 mm compared with LA <55 mm (P for interaction, 0.008).
In MR caused by flail leaflets, LA diameter ≥55 mm is associated with increased mortality under medical treatment, independent of the presence of symptoms or left ventricular dysfunction.
左心房(LA)扩大在器质性二尖瓣反流(MR)中很常见,并且是一种新兴的预后指标。然而,在常规临床实践和多中心研究中,尚未分析 LA 扩大对结局的影响。
二尖瓣反流国际数据库(MIDA)注册登记了因连枷样二尖瓣瓣叶导致的器质性 MR 患者,这些患者在常规临床实践中被诊断,在 5 个美国和欧洲中心入组。我们在 788 例窦性心律患者(64±12 岁;中位数 LA 直径 48[43 至 52]mm)中研究了 LA 直径与药物治疗和二尖瓣手术后死亡率的关系。LA 直径与诊断后的生存独立相关(风险比,每增加 1mm 为 1.08[1.04 至 1.12])。与 LA<55mm 的患者相比,LA≥55mm 的患者 8 年总生存率较低(P<0.001)。LA≥55mm 独立预测总死亡率(风险比,3.67[1.95 至 6.88])和药物治疗中心脏死亡率(风险比,3.74[1.72 至 8.13])。LA≥55mm 与死亡率的相关性在亚组中一致。在无症状和有症状的患者中,LA≥55mm 与死亡率增加相关(交互 P 值为 0.77)。在接受二尖瓣手术的患者中,LA≥55mm 对术后结局没有影响(P>0.20)。与 LA<55mm 的患者相比,LA≥55mm 的患者接受二尖瓣手术后生存获益更大(交互 P 值为 0.008)。
在因连枷样瓣叶导致的 MR 中,LA 直径≥55mm 与药物治疗下死亡率增加相关,独立于症状或左心室功能障碍的存在。